NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 175 filers reported holding NXSTAGE MEDICAL INC in Q3 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,256,000 | -66.3% | 81,748 | -69.4% | 0.01% | -73.7% |
| Q2 2017 | $6,691,000 | +33.9% | 266,900 | +33.4% | 0.04% | +8.6% |
| Q3 2016 | $4,998,000 | +2.6% | 200,000 | -38.5% | 0.04% | -5.4% |
| Q1 2016 | $4,872,000 | -62.8% | 325,000 | -45.7% | 0.04% | -65.7% |
| Q4 2015 | $13,109,000 | -16.3% | 598,300 | -39.8% | 0.11% | -12.2% |
| Q3 2015 | $15,667,000 | -41.3% | 993,500 | -46.9% | 0.12% | -33.5% |
| Q2 2015 | $26,707,000 | +55.2% | 1,869,600 | +88.0% | 0.18% | +58.1% |
| Q1 2015 | $17,208,000 | +93.8% | 994,705 | +100.9% | 0.12% | +88.7% |
| Q4 2014 | $8,879,000 | -32.7% | 495,200 | -50.7% | 0.06% | -37.4% |
| Q3 2014 | $13,200,000 | -5.6% | 1,005,300 | +3.3% | 0.10% | +10.0% |
| Q2 2014 | $13,985,000 | – | 973,200 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burren Capital Advisors Ltd | 29,200 | $806,000 | 9.11% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 7,982,916 | $220,326,000 | 3.72% |
| DAFNA Capital Management LLC | 216,119 | $5,965,000 | 3.70% |
| Versor Investments LP | 406,502 | $11,219,000 | 3.67% |
| Trellus Management Company, LLC | 80,000 | $2,204,000 | 3.02% |
| Pennant Capital Management, LLC | 1,622,066 | $44,769,000 | 2.75% |
| KOPP INVESTMENT ADVISORS LLC | 106,586 | $2,942,000 | 2.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,579,285 | $43,588,000 | 1.96% |
| Cheyne Capital Management (UK) LLP | 190,000 | $5,243,000 | 1.89% |
| First Light Asset Management, LLC | 183,592 | $5,067,000 | 1.60% |